1991 (landmark Italian trial): A double-blind, placebo-controlled trial involving 130 patients with Alzheimer's disease demonstrated that one year of ALCAR treatment resulted in a slower rate of deterioration compared to placebo across 13 of 14 outcome measures, including significant improvements in the Blessed Dementia Scale, logical intelligence, verbal critical abilities, long-term verbal memory, and selective attention [5][17]
Reishi mushroom, scientifically known as Ganoderma lucidum, exhibited noteworthy modulatory effects on the enzymatic activity of hepatic phase 1 and phase 2 biotransformation enzymes [2]
Older adults observed over a 5-year period have also been shown to experience age-related decreases in D2 receptor availability due to aging [87]
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor 1) is a powerful research analogue engineered for superior receptor engagement and stability compared to native IGF-1
The results are consistent, predictable, and significantly better than using either compound in isolation
Vecchiet L et al